# Structural Inequity

In political economy, does the architecture of global clinical research create structural barriers that systematically disadvantage African participation regardless of individual country effort? This structural analysis evaluated 23,873 African trials against seventeen indicators of research infrastructure maturity including regulatory capacity, institutional density, and funding diversity using ClinicalTrials.gov metadata. Africa scored an estimated fourteen percent on a composite research infrastructure index compared to ninety-two percent for Europe and ninety-five percent for North America. The structural deficit was self-reinforcing: low infrastructure attracted foreign-sponsored validation trials that built minimal local capacity, which perpetuated low infrastructure scores. Even Africa's fastest-growing research nation grew from 678 to 11,599 trials without meaningfully changing its structural position relative to high-income comparators. These findings demonstrate that research inequity is architectural rather than incidental and requires structural reform rather than incremental investment. Interpretation is limited by the composite index methodology which assigns equal weight to heterogeneous infrastructure dimensions.

## References

1. Isaakidis P, et al. "Relation between burden of disease and randomised evidence in sub-Saharan Africa." BMJ. 2002;324:702.
2. Lang T, Siribaddana S. "Clinical trials have gone global: is this a good thing?" PLoS Med. 2012;9:e1001228.

## Note Block

- Type: research
- App: https://mahmood726-cyber.github.io/africa-e156-students/governance-justice/dashboards/structural-inequity.html
- Code: https://github.com/mahmood726-cyber/africa-e156-students/blob/master/governance-justice/code/structural-inequity.py
- Data: ClinicalTrials.gov API v2
- Date: 2026-04-05